NEXT Financial Group Inc Has $4.76 Million Position in Johnson & Johnson (JNJ)
NEXT Financial Group Inc trimmed its position in Johnson & Johnson (NYSE:JNJ) by 4.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 34,914 shares of the company’s stock after selling 1,607 shares during the period. Johnson & Johnson makes up 1.3% of NEXT Financial Group Inc’s holdings, making the stock its 6th biggest holding. NEXT Financial Group Inc’s holdings in Johnson & Johnson were worth $4,763,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of JNJ. Harding Loevner LP bought a new stake in Johnson & Johnson in the second quarter valued at $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in Johnson & Johnson by 29.9% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after acquiring an additional 200 shares in the last quarter. IHT Wealth Management LLC boosted its holdings in Johnson & Johnson by 46.4% in the second quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after acquiring an additional 3,467 shares in the last quarter. Mountain Capital Investment Advisors Inc bought a new stake in Johnson & Johnson in the second quarter valued at $124,000. Finally, Shine Investment Advisory Services Inc. bought a new stake in Johnson & Johnson in the second quarter valued at $177,000. 65.58% of the stock is currently owned by institutional investors.
Several research firms recently weighed in on JNJ. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price target on the stock in a report on Thursday, January 11th. Stifel Nicolaus lifted their price target on shares of Johnson & Johnson from $142.00 to $145.00 and gave the company a “hold” rating in a report on Wednesday, January 24th. BMO Capital Markets lifted their price target on shares of Johnson & Johnson to $161.00 and gave the company an “outperform” rating in a report on Tuesday, December 12th. BTIG Research reiterated a “sell” rating and issued a $110.00 price target on shares of Johnson & Johnson in a report on Wednesday, January 24th. Finally, JPMorgan Chase & Co. cut shares of Johnson & Johnson from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 2nd. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Johnson & Johnson presently has an average rating of “Hold” and an average target price of $146.16.
Shares of Johnson & Johnson (NYSE JNJ) opened at $129.91 on Thursday. Johnson & Johnson has a fifty-two week low of $119.25 and a fifty-two week high of $148.32. The company has a market cap of $349,010.00, a price-to-earnings ratio of 333.10, a PEG ratio of 2.23 and a beta of 0.74. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36.
Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.02. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.08 billion. During the same quarter in the previous year, the business posted $1.58 EPS. The company’s quarterly revenue was up 11.5% on a year-over-year basis. sell-side analysts forecast that Johnson & Johnson will post 8.11 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Tuesday, February 27th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date of this dividend is Monday, February 26th. Johnson & Johnson’s dividend payout ratio (DPR) is presently 861.54%.
WARNING: “NEXT Financial Group Inc Has $4.76 Million Position in Johnson & Johnson (JNJ)” was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2018/02/22/next-financial-group-inc-has-4-76-million-position-in-johnson-johnson-jnj.html.
Johnson & Johnson Company Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.